[PLX] QoQ Quarter Result on 31-Mar-2011 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
04-May-2011
Financial Year
2011
Quarter
31-Mar-2011 [#Q1]
Profit Trend
QoQ- 40.76%
YoY- 36.49%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 2,362 1,132 764 6,000 1,176 3,184 1,141 62.21%
PBT 968 0 179 -5,052 22,414 0 0 -
Tax -27,616 108 20,699 0 -20,470 -374 -109 3863.79%
NP -8,913 -8,875 -13,689 -5,052 -8,528 -2,474 -10,041 -7.61%
Tax Rate 2,852.89% - -11,563.69% - 91.33% - - -
Total Cost 11,275 10,007 14,453 11,052 9,704 5,658 11,182 0.55%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin -377.35 -784.01 -1,791.75 -84.20 -725.17 -77.70 -880.02 -43.04%
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
EPS -1.01 -0.10 -0.16 -0.06 -1.04 -0.03 -0.12 312.16%
EPS Diluted -1.01 -0.10 -0.16 -0.06 -1.04 -0.03 -0.12 312.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.